Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells. (From Jablonski's Dictionary of Dentistry, 1992, p400)
Excessive hair growth at inappropriate locations, such as on the extremities, the head, and the back. It is caused by genetic or acquired factors, and is an androgen-independent process. This concept does not include HIRSUTISM which is an androgen-dependent excess hair growth in WOMEN and CHILDREN.
Surgical excision of the gingiva at the level of its attachment, thus creating new marginal gingiva. This procedure is used to eliminate gingival or periodontal pockets or to provide an approach for extensive surgical interventions, and to gain access necessary to remove calculus within the pocket. (Dorland, 28th ed)
Generalized or localized diffuse fibrous overgrowth of the gingival tissue, usually transmitted as an autosomal dominant trait, but some cases are idiopathic and others produced by drugs. The enlarged gingiva is pink, firm, and has a leather-like consistency with a minutely pebbled surface and in severe cases the teeth are almost completely covered and the enlargement projects into the oral vestibule. (Dorland, 28th ed)
Oral tissue surrounding and attached to TEETH.
An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).
Excessive growth of the gingiva either by an increase in the size of the constituent cells (GINGIVAL HYPERTROPHY) or by an increase in their number (GINGIVAL HYPERPLASIA). (From Jablonski's Dictionary of Dentistry, 1992, p574)
'Gingival diseases' is a general term for conditions affecting the soft tissues surrounding and supporting the teeth, primarily characterized by inflammation, bleeding, redness, or swelling, which can progress to periodontal disease if left untreated.

Impact of cyclosporin A pharmacokinetics on the presence of side effects in pediatric renal transplantation. (1/44)

Cyclosporin A (CsA) is a potent immunosuppressant that has many side effects, including hypertrichosis, gingival hyperplasia, and tremor. To evaluate whether there is a relationship between the CsA-pharmacokinetics (PK) and these side effects, their presence and intensity were observed in 46 renal transplanted children/adolescents during two regular visits, and the occurrence of the side effects was correlated with CsA-PK. CsA doses had been unchanged for at least 6 mo. CsA blood concentrations were measured at time 0, and 1, 2, and 4 h after the CsA morning dose. An abbreviated area under the curve (AUC) was calculated using C0, C2, and C4. Hypertrichosis positively correlated with C2, C4, Cmax, and AUC. An AUC > or = 4158 ng/ml per h was the best predictor for the presence of hypertrichosis. Tremor was also positively correlated with C2, Cmax, and AUC. A Cmax > or = 878 ng/ml was the best predictor for the appearance of tremor. These values of Cmax and AUC are within the therapeutic range of CsA as demonstrated by the studies of calcineurin inhibition by CsA. Gingival hyperplasia was not associated with any of the CsA-PK studied parameters. However, it was associated with the concomitant use of nifedipine. These data show that there is a correlation between the CsA side effects and its pharmacokinetics and that it is possible to decrease the incidence and intensity of such side effects by monitoring the CsA-PK parameters, providing they are under or at the proposed cutoff levels. Nifedipine should also be avoided to reduce the presence of gingival hyperplasia.  (+info)

Diphenylhydantoin (dilantin) gingival hyperplasia: drug-induced abnormality of connective tissue. (2/44)

Various degrees of gingival overgrowth may occur in individuals taking diphenylhydantoin, a drug used widely in the treatment of epilepsy. The tissue overgrowth is made up predominantly of collagen, and may therefore be a useful model for analysis of fibrosis and some other connective tissue abnormalities. Fibroblasts derived from the overgrown tissue exhibit a level of protein synthetic activity approximately twice that of comparable cells obtained from nonepileptic control individuals and from the gingiva of age-matched epileptics taking the drug but not exhibiting gingival enlargement. In addition, 20% of the protein synthesized by cells from the affected tissue is collagen, whereas collagen accounts for only about 11% of the total protein produced by control cells of both types. The drug appears to induce or select for fibroblasts characterized by enhanced levels of protein synthesis and collagen production. This alteration persists through several cell replications in vitro in the absence of drug.  (+info)

Gingival hyperplasia complicating acute myelomonocytic leukemia. (3/44)

Many systemic illnesses manifest clinical signs in the oral cavity. A remarkable case of gingival hyperplasia heralding the presence of acute myelomonocytic leukemia (AML FAB-M4) is described. The oral manifestations of acute leukemia are reviewed.  (+info)

Drug-induced gingival hyperplasia in transplant recipients. (4/44)

Gingival hyperplasia is a common occurrence in transplant recipients who are taking cyclosporine. This condition can be complicated when calcium channel blockers or phenytoin are added to the armamentarium of medications; it can be painful and may interfere with eating, speech, and appearance. Multiple mechanisms exist for gingival overgrowth. Prevention with appropriate oral hygiene appears important in controlling the inflammatory component and decreasing the severity of the overgrowth. Patients must be aware of the potential for the development of gingival hyperplasia and must follow up with regular professional cleanings. If the overgrowth persists, treatment options should be discussed between patients and their physician. Conversion from cyclosporine to tacrolimus, treatment with antibiotic therapy, and surgical excision or laser therapy are all potential therapies to consider.  (+info)

An involvement of granulocyte medullasin in phenytoin-induced gingival overgrowth in rats. (5/44)

To investigate the relationship between histological changes and distributions of medullasin, a neutrophil elastase-like serine proteinase, in phenytoin-induced gingival overgrowth, we established a rat model of gingival overgrowth. Thirty-two, 20-day-old male Fischer 344 rats were fed a diet containing phenytoin and sacrificed at 1, 2, 4 and 8 weeks. Control rats (n = 40) were fed the same diet, but without the drug and killed at the same weeks as experimental rats (n = 32) and 0 week (n = 8). The mandible specimens were resected and sectioned bucco-lingually between the first and second molars. A marked inflammatory-cell infiltration and elongated rete pegs were seen in the phenytoin-treated group. The extent of the overgrowth assessed by computer image analysis and the density of medullasin-positive cells by immunohistochemistry in the approximal gingiva showed a significant increase in the phenytoin-treated group compared to the control group. A marked infiltration of the positive cells in experimental rats was observed as early as 2 weeks when gingival overgrowth was not fully established. Medullasin-positive cells were mostly neutrophils and partly macrophage-like cells. These findings suggest that medullasin may be involved in mainly host defense and secondarily collagen metabolism in the phenytoin-induced rat model of gingival overgrowth.  (+info)

Idiopathic gingival hyperplasia and orthodontic treatment: a case report. (6/44)

There are many reasons for gingival hyperplasia. Mostly, proper oral hygiene is sufficient to achieve normal healthy gingiva. In some situations, however, gingival hyperplasia is drug-induced or can be a manifestation of a genetic disorder. In the latter, it may exist as an isolated abnormality or as part of a syndrome. If orthodontic treatment is needed in patients with gingival hyperplasia, both orthodontic and periodontal aspects need to be considered. Extreme hereditary gingival fibromatosis was periodontally treated, by removal of all gingival excess using flaps and gingivectomies. After a follow-up period, the orthodontic treatment started with fixed appliances. Monthly periodontal check-ups (scaling and polishing) were scheduled to control the gingival inflammation. After the orthodontic treatment, permanent retention was applied, once more followed by a complete gingivectomy in both maxilla and mandible. One of the most important keys to successful treatment of hyperplasia patients is the cooperation between the periodontist and the orthodontist.  (+info)

Cytomegalovirus-induced gingival hyperplasia. (7/44)

We report a rare presentation of gingival hyperplasia associated with cytomegalovirus infection in a 33-year-old human immunodeficiency virus-infected man.  (+info)

Superinfecting microorganisms in patients under treatment with cyclosporin-A and its correlation to gingival overgrowth. (8/44)

The aim of this study was to identify the presence of superinfecting microorganisms (Gram-negative enteric rods and Candida sp.) in heart transplant patients and correlate this with gingival overgrowth. Thirty patients (10 females, 20 males--mean age 45 years) were examined. All were under cyclosporin-A (CsA) therapy. Patients who had taken any antibiotics 3 months prior the study or had been submitted to periodontal therapy were not enrolled. Patients were required to have at least 6 teeth. The plaque index (PI), gingival index (GI), pocket depth (PD) and clinical attachment level (CAL) were recorded. Microbiological samples were taken from sulcus/pocket (s/p) and from stimulated saliva (ss) and submitted to analysis. Patients were divided into two groups: the ones with gingival overgrowth (GO) and those without gingival overgrowth (WGO). After statistical analysis (chi-square test, Student's t-test, Fisher test, p < or = 0.05), we concluded that there was no statistical difference between groups in the parameters of gender, CsA dosage, time since transplantation, PI, GI, PD and CAL. Gram-negative rods from either the sulcus/pocket or saliva samples were not found. Candida sp. was detected (s/p-30% and ss-30%). Stimulated saliva samples analysis determined that the presence of Candida sp. was associated with patients without gingival overgrowth.  (+info)

Gingival hyperplasia is a condition characterized by an abnormal growth or enlargement of the gingiva (gum tissue). This condition can be caused by various factors, including bacterial infection, certain medications (such as phenytoin, cyclosporine, and nifedipine), systemic diseases (such as leukemia, vitamin C deficiency, and Crohn's disease), and genetic disorders.

The enlarged gum tissue can be uncomfortable, irritated, and prone to bleeding, especially during brushing or flossing. It may also make it difficult to maintain good oral hygiene, which can increase the risk of dental caries and periodontal disease. Treatment for gingival hyperplasia typically involves improving oral hygiene, controlling any underlying causes, and in some cases, surgical removal of the excess tissue.

Hypertrichosis is a medical term that refers to an abnormal growth or overabundance of hair in areas where hair is not typically found or excessively thick. It can affect both men and women, and it can be present at birth (congenital) or develop later in life (acquired). The cause of congenital hypertrichosis is usually genetic, while acquired hypertrichosis can be caused by various factors such as medications, hormonal imbalances, metabolic disorders, or cancer.

Hypertrichosis should not be confused with hirsutism, which is a condition that causes excessive hair growth in women in areas where hair is typically found in men, such as the face, chest, and back. Hirsutism is usually caused by hormonal imbalances, while hypertrichosis can occur anywhere on the body.

Hypertrichosis can be localized, affecting only specific areas of the body, or generalized, affecting large portions of the body. Treatment for hypertrichosis depends on the underlying cause and may include medications to slow hair growth, laser therapy, or hair removal methods such as waxing, shaving, or plucking.

A gingivectomy is a dental procedure that involves the surgical removal or reshaping of the gum tissue (gingiva) to improve the health and appearance of the teeth and gums. This procedure is typically performed when the gums have become swollen, inflamed, or infected due to periodontal disease, which can cause the gums to recede and expose the tooth roots. By removing the affected gum tissue, a gingivectomy can help to eliminate pockets of bacteria and promote healthy gum growth.

During the procedure, a dental surgeon will use local anesthesia to numb the area and then carefully cut away the excess gum tissue using specialized instruments. The surgeon may also smooth and reshape the remaining gum tissue to create a more even and aesthetically pleasing appearance. After the procedure, patients may experience some discomfort, swelling, or bleeding, but these symptoms can typically be managed with over-the-counter pain medications and careful oral hygiene practices.

It's important to note that while a gingivectomy can help to improve the health of the gums and teeth, it is not a substitute for good oral hygiene habits. Regular brushing, flossing, and dental checkups are essential for maintaining healthy teeth and gums over the long term.

Gingival fibromatosis is a benign (non-cancerous) condition characterized by the excessive growth of gum (gingival) tissue. The overgrowth can affect one or both the maxilla (upper jaw) and mandible (lower jaw) and can lead to various dental and oral health issues, such as difficulty in chewing, speaking, and maintaining proper oral hygiene.

The etiology of gingival fibromatosis can be divided into two categories: hereditary and acquired. Hereditary gingival fibromatosis is often associated with genetic mutations, while acquired gingival fibromatosis can result from factors like chronic inflammation due to poor oral hygiene, certain medications (such as phenytoin, cyclosporine, or nifedipine), and systemic conditions (like leukemia).

The management of gingival fibromatosis typically involves surgical removal of the excess tissue. However, recurrence is common due to the condition's tendency for regrowth. Regular follow-ups with a dental professional are essential to monitor any potential regrowth and maintain good oral hygiene.

Gingiva is the medical term for the soft tissue that surrounds the teeth and forms the margin of the dental groove, also known as the gum. It extends from the mucogingival junction to the base of the cervical third of the tooth root. The gingiva plays a crucial role in protecting and supporting the teeth and maintaining oral health by providing a barrier against microbial invasion and mechanical injury.

Hyperplasia is a medical term that refers to an abnormal increase in the number of cells in an organ or tissue, leading to an enlargement of the affected area. It's a response to various stimuli such as hormones, chronic irritation, or inflammation. Hyperplasia can be physiological, like the growth of breast tissue during pregnancy, or pathological, like in the case of benign or malignant tumors. The process is generally reversible if the stimulus is removed. It's important to note that hyperplasia itself is not cancerous, but some forms of hyperplasia can increase the risk of developing cancer over time.

Cyclosporine is a medication that belongs to a class of drugs called immunosuppressants. It is primarily used to prevent the rejection of transplanted organs, such as kidneys, livers, and hearts. Cyclosporine works by suppressing the activity of the immune system, which helps to reduce the risk of the body attacking the transplanted organ.

In addition to its use in organ transplantation, cyclosporine may also be used to treat certain autoimmune diseases, such as rheumatoid arthritis and psoriasis. It does this by suppressing the overactive immune response that contributes to these conditions.

Cyclosporine is available in capsule, oral solution, and injectable forms. Common side effects of the medication include kidney problems, high blood pressure, tremors, headache, and nausea. Long-term use of cyclosporine can also increase the risk of certain types of cancer and infections.

It is important to note that cyclosporine should only be used under the close supervision of a healthcare provider, as it requires regular monitoring of blood levels and kidney function.

Gingival overgrowth, also known as gingival hyperplasia or hypertrophy, refers to an abnormal enlargement or growth of the gum tissue (gingiva) surrounding the teeth. This condition can be caused by various factors, including poor oral hygiene, certain medications (such as phenytoin, cyclosporine, and calcium channel blockers), genetic predisposition, and systemic conditions like vitamin C deficiency or leukemia.

Gingival overgrowth can lead to several complications, such as difficulty in maintaining oral hygiene, which may result in periodontal disease, tooth decay, bad breath, and potential loss of teeth. In some cases, the enlarged gum tissue may also cause discomfort or pain during speaking, chewing, or brushing. Treatment for gingival overgrowth typically involves improving oral hygiene, adjusting medications if possible, and undergoing surgical procedures to remove the excess gum tissue. Regular dental check-ups and cleanings are essential in managing and preventing this condition.

Gingival diseases are infections or inflammations that affect the gingiva, which is the part of the gum around the base of the teeth. These diseases can be caused by bacteria found in dental plaque and can lead to symptoms such as redness, swelling, bleeding, and receding gums. If left untreated, gingival diseases can progress to periodontal disease, a more serious condition that can result in tooth loss. Common types of gingival diseases include gingivitis and periodontitis.

... is a cutaneous condition characterized by enlargement of the gums noted during the first year ... Although the mechanism of drug related gingival hyperplasia is not well understood, some risk factors for the condition include ... ISBN 978-1-4160-2999-1. Mohan, RP; Rastogi, K; Bhushan, R; Verma, S (23 April 2013). "Phenytoin-induced gingival enlargement: a ... "Management of amlodipine-induced gingival enlargement: Series of three cases". Journal of Indian Society of Periodontology. 14 ...
The terms gingival hyperplasia and gingival hypertrophy have been used to describe this topic in the past. These are not ... Gingival enlargement is an increase in the size of the gingiva (gums). It is a common feature of gingival disease. Gingival ... This type of gingival enlargement is sometimes termed "drug induced gingival enlargement" or "drug influenced gingival ... Ciancio, SG (1972). "Gingival hyperplasia and diphenylhydantoin". Journal of Periodontology. 43 (7): 411-4. doi:10.1902/jop. ...
Steele RM, Schuna AA, Schreiber RT (April 1994). "Calcium antagonist-induced gingival hyperplasia". Annals of Internal Medicine ... Along with other calcium channel blockers, verapamil is known to induce gingival enlargement. Acute overdose is often ...
Other reported features include pain and gingival hyperplasia. Pain is thought to be a rare symptom and is usually linked to an ... that the accumulation of plaque had led to the development of inflammation coupled with an increase in the gingival infiltrate ...
This condition is usually accompanied by gingival hyperplasia. This form is most responsible for the term "werewolf syndrome" ... The scientist Rudolf Virchow described a form of hypertrichosis accompanied by gingival hyperplasia in 1873. In summer 2019, at ... the generalized form of the syndrome coupled with her gingival hyperplasia indicated that her condition was congenital terminal ... Mutations on Chromosome 17q24.2-q24.3 in Congenital Generalized Hypertrichosis Terminalis with or without Gingival Hyperplasia ...
In dogs, the primary side effect is gingival hyperplasia. "Medical Definition of AMLODIPINE". www.merriam-webster.com. Archived ... gingival enlargement, hepatitis, and jaundice. Amlodipine-associated gingival overgrowth is a relatively common side effect ... Gaur S, Agnihotri R (June 2018). "Is dental plaque the only etiological factor in Amlodipine induced gingival overgrowth? A ... 2010). "Prevalence of Amlodipine-induced Gingival Overgrowth". International Journal of Oral-Medical Sciences. 9 (2): 96-100. ...
"Effectiveness of CO2 laser in removal of papillary gingival hyperplasia". Dental Press Journal of Orthodontics. 17 (2): 33.e1- ... Where a patient presents with an unsightly gummy smile due to too much gingival coverage of tooth crown, especially the upper ... Laser gingivectomy is a dental procedure that recontours or scalpels the gingival tissue to improve long term dental health or ... "Combined treatment approach of gingivectomy and CO2 laser for cyclosporine-induced gingival overgrowth". www.quintpub.com. ...
... (DIGE), also referred to as drug-induced gingival hyperplasia (DIGH) or drug-induced gingival ... Common immunosuppressive drugs linked to gingival hyperplasia are cyclosporin and tacrolimnus. The most frequently used ... If gingival overgrowth becomes a legitimate concern, initial management would be proper oral hygiene habits as it is the least ... The main classes of drugs that result in gingivlal hyperplasia are as follows. Anticonvulsant agents, such as phenytoin, are ...
"Ablation and sulcular debridement utilizing the CO2 laser for denture-induced gingival hyperplasia". Implant Practice US. 8 (2 ...
Diseases include leukoplakia, epulis, gingival hyperplasia, gingivitis, periodontitis and aphthous ulcer (canker sore). To ...
Bubna AK, Veeraraghavan M, Anandan S, Rangarajan S (2015). "Congenital Generalized Hypertrichosis, Gingival Hyperplasia, a ...
Pocket depths greater than 3 mm can also be a sign of gingival hyperplasia. The periodontal probe can also be used to measure ... The tip of the instrument is placed with light pressure of 10-20 grams into the gingival sulcus, which is an area of potential ... However, in patients who smoke, the gingival tissue rarely bleeds because of unknown factors that do not seem related to dental ... other dental instruments, tooth preparations during restorative procedures, gingival recession, attached gingiva, and oral ...
A mutation at this locus has been associated with amelogenesis imperfecta and gingival hyperplasia syndrome. Alternatively ... and gingival hyperplasia syndrome. Human mutations in FAM20A were also reported to cause Enamel-Renal Syndrome, an autosomal ... "Whole-Exome sequencing identifies FAM20A mutations as a cause of amelogenesis imperfecta and gingival hyperplasia syndrome". Am ...
... (HGF), also known as idiopathic gingival hyperplasia, is a rare condition of gingival ... Source 1) Later on in 2010, there was a case study done on a 16-year-old male with severe gingival overgrowth, almost covering ... SOURCE 2) In some cases, there is re-growth after surgical removal of the excess gingival tissues, in others there is minimal. ... View at Publisher • View at Google Scholar U. Khan, S. Mustafa, Z. Saleem, A. Azam, and Z. A. Khan, "Hereditary gingival ...
Hormonal changes increase blood flow to gum tissue often resulting in gingival hyperplasia and gum bleeding while brushing and ...
The latter condition was caused by a rare disease, undiagnosed in her lifetime, gingival hyperplasia, which thickened her lips ...
... these patients are more likely to have gingival hyperplasia, aphthous ulceration, herpes simplex virus, oral leucoplakia; which ... They can cause gingival hypertrophy (overgrowth), particularly dihydropyridine and nifidipine. Poor dental hygiene and inflamed ... Livada, R.; Shiloah, J. (January 2014). "Calcium channel blocker-induced gingival enlargement". Journal of Human Hypertension. ...
... and removal of gingival hyperplasia and epulides. Cats - Dental prophylaxis as described above for the dog and treatment and ...
These include missing, rotated, and fractured teeth, probing depths of gingival recession, enamel hyperplasia or other enamel ... The probe is inserted into the gingival sulcus to measure its depth. Normal sulcus depth in the dog is < 3 mm and < 1 mm in ... They appear as an overgrowth of gingival or pulpal tissue. The lesions erode the dentin within a single tooth (or several ... Tromp, J. a. H.; Jansen, J.; Pilot, T. (1986). "Gingival health and frequency of tooth brushing in the beagle dog model". ...
... and gingival hyperplasia. The earliest known case of AI is in an extinct hominid species called Paranthropus robustus, with ...
... or drug induced gingival hyperplasia. Regardless of the etiology, when gingival hyperplasia occurs, greater than normal (the ... In a gingival pocket, no destruction of the connective tissue fibers (gingival fibers) or alveolar bone occurs. This early sign ... The interface between a tooth and the surrounding gingival tissue is a dynamic structure. The gingival tissue forms a crevice ... In this state, much of the gingival fibers that initially attached the gingival tissue to the tooth have been irreversibly ...
When gingival hyperplasia is confined to one area of the jaw, this is when it is termed an epulis fibrosa, caused by an ... This is a fibrous hyperplasia of excess connective tissue folds that takes place in reaction to chronic trauma from an ill ... It seems to grow from below the free gingival margin/interdental papilla. This epulis most commonly occurs on the gingiva near ... Epulis (Greek: ἐπουλίς; plural epulides) is any tumor like enlargement (i.e. lump) situated on the gingival or alveolar mucosa ...
Keglevich T, Benedek E, Gera I (December 1999). "[Clinical experience with the treatment of gingival hyperplasia induced by ... Another cause of gingival enlargement would be a hereditary condition known as gingival fibromatosis. The extensive overgrowth ... creating a favourable environment for gingival healing and restoration of a physiologic gingival contour. The procedure may ... to achieve an aesthetically pleasing gingival architecture blending in harmoniously the gingival contours of the maxillary ...
Chemotherapy-induced hyperpigmentation Drug-induced acne Drug-induced angioedema Drug-related gingival hyperplasia Drug-induced ... Gingival fibroma Gingival hypertrophy Hairy leukoplakia (oral hairy leukoplakia) Intraoral dental sinus Linea alba Leukoplakia ... Spiegler-Fendt lymphoid hyperplasia, Spiegler-Fendt sarcoid) Cutaneous lymphoid hyperplasia with bandlike and perivascular ... Angiolymphoid hyperplasia with eosinophilia (epithelioid hemangioma, histiocytoid hemangioma, inflammatory angiomatous nodule, ...
In addition, there is the presence of ulceration with gingival hyperplasia, including the formation of rete ridges and ... which lines the gingival sulcus from the base to the free gingival margin, where it interfaces with the epithelium of the oral ... the probing depth of the gingival sulcus may be considerably different from the true histological gingival sulcus depth. The ... The gingival sulcus is bounded by the enamel of the crown of the tooth and the sulcular epithelium. Immediately apical to the ...
As calcium channel blocker, nifedipine has a risk of causing gingival hyperplasia A number of persons have developed toxicity ...
Hirschsprung microcephaly cleft palate Hirschsprung nail hypoplasia dysmorphism Hirsutism congenital gingival hyperplasia ... Hemi 3 syndrome Hemifacial atrophy agenesis of the caudate nucleus Hemifacial atrophy progressive Hemifacial hyperplasia ... Hyperimmunoglobulinemia D with periodic fever Hyperimmunoglobulinemia E Hyperinsulinism due to focal adenomatous hyperplasia ...
... through contributing to various oral conditions such as dry mouth and gingival enlargement (gingival hyperplasia). It is ... 81 Periodontal health and gingival health Clinical gingival health on an intact periodontium Clinical gingival health on a ... The gingival pocket between the tooth and the gingival should be no deeper than 1-3mm to be considered healthy. There is also ... The gingival sulcus is lined by a non-keratinised layer called the oral sulcular epithelium; it begins at the gingival margin ...
This can present as painful, red and swollen tissues, especially at the gingival margin. As a result, gingival recession may ... Plaque build up around overdenture abutments or precision attachments can lead to inflammation and hyperplasia of the gingiva. ... Caries can be found at the root face or root surface where gingival recession has occurred. It is important to encourage ...
... characterized by an overgrowth of the facial and cranial bones Hereditary gingival fibromatosis a rare condition of gingival ... is the collection of small animals and plants that adhere to open surfaces Hyperplasia Inflammatory papillary hyperplasia, ... in which there is an abnormal increase in the size of the body or a body part Small intestinal bacterial overgrowth Gingival ...

No FAQ available that match "gingival hyperplasia"

No images available that match "gingival hyperplasia"